Heterogeneous Patterns of Marijuana Use Motives Using Latent Profile Analysis

Abstract

Background: Given that marijuana use is often associated with detrimental physical and mental health problems, research examining motives for its use is critical for effective remedial and preventive treatment. To date, the majority of research on marijuana use motives has used variable-centered analyses, which overlooks potentially meaningful heterogeneous response patterns and the associations of those patterns with other risk/protective factors. Methods: To address this gap, in the current study, we conducted a person-centered analysis (latent profile analysis) to identify subgroups of participants based on endorsed marijuana use motives, and examined the construct validity of the optimal class solution (covariates included sociodemographic (e.g., age), psychiatric (e.g., depression), and marijuana-use indices (e.g., use-frequency, use-related problems). Participants were 898 college students (M_age = 20.93, SD_age = 3.10; 68.9% female) who completed an anonymous online survey examining substance use and psychological well-being, were 18 years or older, and endorsed lifetime marijuana use. Data were collected November 2016 through February 2018. Results: Results identified four unique classes of coping, conformity, social, and enhancement marijuana use motives: (a) “Low Motives” (37.6%), (b) “High Conformity” (4.9%), (c) “Low Conformity” (45.8%), and (d) “High Motives” (11.7%). In terms of covariates, higher motive classes tended to report more frequent and problematic use. The two classes uniquely characterized by conformity motives only differed on past-month marijuana use frequency. Conclusions/Importance: The current findings provide evidence that specific classes of motives were not only associated with marijuana use frequency and problems but other risk and protective factors, such as anxiety sensitivity and social support.

Keywords:

• Marijuana motives
• latent profile analysis
• person-centered

Additional information

Funding

Renee Cloutier is supported by 5F31DA041105-02 from the National Institute of Drug Abuse (NIDA). Ashley Knapp is supported by 1T32MH115882-01 from the National Institute of Mental Health (NIMH).